Member Info for Laura2022

Csn anyone explain how we can have 700,000 shares bought and only 80,000 sold and yet ee do not go up in price ?

Hello Stephen, Kidlington or PM may know more?

Physiomics will receive a fee (capped at £6m) of 6% of any future net revenues that may be received by ValiRx relating to its commercialisation of VAL201 and its derivatives in any indication, including prostate cancer, endometriosis and treatment for Coronavirus infection......... In recognition of the collaborative nature of this new agreement, Physiomics will also be offered a seat on the ValiRx scientific advisory board

I agree and PYC has 3 links

1 VAL 201

2 Jim M is on VAL scientific advisory board

3 VAL and Pyc formed collaboration recently

Both companies will benefit from any VAL201 deal and we all hope Suzy succeeds

Luckily PYC has over 20 other clients ,including large ones like Bicycle, Merck, Servier so VAL201 would be a great added bonus

We will agree to differ then as PYC from £1.3mln cap with c £800k cash and fully funded has the chance to grow exponentially whereas its unclear on VAL

You've never posted on PYC before so we weren't aware you were invested

Rsslly great news , I forst purchased these over 6mths ago and great to see £8mln

Directors own a large amount as do GRC which myself and Ria have bought

Hi Stephen

They have been showing buys as sells for 2 weeks now, really feels like PYC and A.I is in the spotlight recently

They already own 40%between them so more likely to be another investor

Excellent summary of the potential spending that cone to PYC from long established clients, for confidentiality PYC often aren't allowed to day much but the recent contract used the word "SUBSTANTIAL: which clearly shows q step change from usual .

PYC have recently had new collabs from Bicycle, who raised appox $240m.

They helped with Cellcentric with CCS1477 ( now inobrodib )and they have just raised approx $20m and had fast track orphan status from FDA.

Numab secured $110m funding in 2021.

You could hope that a fraction of those $ or £ raised ( at least ) could come PYC's way to help with projects either already started or in the future from these companies?

Then there is the 6m from VAL for (201) if that ever gets off the ground that is.

If you look at the Numab pipeline link i posted earlier, you can see that 8 of the 9 projects have partners, including: 3SBio/Sunshine Guojian, Boehringer Ingelheim, Eisai, CStone, Ono, Kaken, and Tillotts.

They have 1 which is fully owned by themselves which is NM32-2668

Its not out of the realms of possibilities that IF PYC are helping Numab on pipeline with a partner, then said partner could also be informed of PYC work?

100% rise is quite possible here , that would drill only be 11p whereas it was 14p before the seller situation

£20,000

Large buy has just been purchased

It's one of only a handful of A.I stocks on AIM and £1.3mln cap and £800k cash with clients who have raised $50-200mln to invest in their drug discovery programme) see Kidlington excellent summary a few weeks ago)

Uxm

They also don't and didn't need 1mln they CHOSE to raise c £350

Hope that helps

Expecting significant rise in revenues with increased awareness of benefits of A.I in drug development

· Pipeline: Discussions ongoing with over 25 largely new potential clients regarding projects with an estimated total value of over £1.5m which could be commenced in financial year 2024.

In order to further develop its business and accelerate growth, the Company is raising funds to carry out activities including:

· Further expansion and diversification of its client base;

· Expansion of its consulting business into the adjacent area of pharmaceutical biostatistics services; and

· Exploration of opportunities around its personalised oncology software offering.

 

The raise was for growth not for working capital uxm

They didn't need to raise as they have been low cash burn of about £300,00 and revenues of £900,000 would lead to break even

Big rise should happen based on the fact that the sells have cleared

Thanks

While I read up on these , could you tell me how GRC looks against these measures please

Ria

Please can you tell me what MACD and Rsi mean

Thanks

L

I don't know how to do charts (people keep mentioning RSI and MACD so if someone cam explain that would be useful . However the basic lies that GRC has fallen from 15p to 6p due to unusually large sells makes this appear to be bargain territory

Particularly with the CEO owning 25% and offering unused banking facilities, and where the annual SAAS is worth more than the .current market value

This was from the interims

The Group has banking facilities to provide adequate headroom for unforeseen working capital requirements by way of an invoice discounting facility.

I shall be adding more at this bargain price, results are usually late August and expect them to confirm the positive trajectory of the rre recent trading statement